Results 11 to 20 of about 449,097 (277)

International meeting: New diagnostic tests are urgently needed to treat patients with Chagas disease. [PDF]

open access: yes, 2008
Trypanosoma cruzi infection is often not detected early on or actively diagnosed, partly because most infected individuals are either asymptomatic or oligosymptomatic.
Campaign for Access to Essential Medicines
core   +3 more sources

Essential tuberculosis medicines and health outcomes in countries with a national essential medicines list

open access: yesJournal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2022
Background: Tuberculosis (TB) remains a major cause of morbidity and mortality globally despite effective treatments. Along with high-quality health services, essential medicines are a key tool in curbing TB related mortality.
Darshanand Maraj   +2 more
doaj   +1 more source

Implementation of health technology assessment at the stage of market access for pharmaceuticals in Ukraine

open access: yesФармацевтичний журнал, 2020
Market access for pharmaceuticals is a set of strategies, activities and processes developed by pharmaceutical companies to provide affordable medicines at appropriate fair prices in a particular health care system.
O. B. Piniazhko   +5 more
doaj   +1 more source

Can NGOs Regulate Medicines Markets? Social Enterprise in Wholesaling, and Access to Essential Medicines. [PDF]

open access: yes, 2011
Citizens of high income countries rely on highly regulated medicines markets. However low income countries' impoverished populations generally struggle for access to essential medicines through out-of-pocket purchase on poorly regulated markets; results ...
Chaudhuri, Sudip   +2 more
core   +4 more sources

Legislating for universal access to medicines : a rights-based cross-national comparison of UHC laws in 16 countries [PDF]

open access: yes, 2019
Universal health coverage (UHC) aims to ensure that all people have access to health services including essential medicines without risking financial hardship. Yet, in many low- and middle-income countries (LMICs) inadequate UHC fails to ensure universal
Alexandrov, Nikita V   +2 more
core   +1 more source

Laudato Si’: a bridge towards access to medicines

open access: yesVigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia, 2018
Pope Francis’ Encyclical Laudato Si’, albeit not explicitly, has drawn attention worldwide to the access to medicines as a fundamental human right, as it raises awareness about the current situation of the world and the poor.
Jorge Antonio Zepeda Bermudez   +6 more
doaj   +7 more sources

Promotion of access to essential medicines for Non-Communicable Diseases: Practical implications of the UN Political Declaration [PDF]

open access: yes, 2013
Access to medicines and vaccines to prevent and treat non-communicable diseases (NCDs) is unacceptably low worldwide. In the 2011 UN political declaration on the prevention and control of NCDs, heads of government made several commitments related to ...
Abdraimova   +60 more
core   +3 more sources

New diagnostics for tuberculosis: fulfilling patient needs first

open access: yesJournal of the International AIDS Society, 2010
Background An effective tuberculosis (TB) control programme requires early diagnosis and immediate initiation of treatment. Any delays in diagnosing TB not only impair a patient's prognosis, but also increase the risks of transmitting the disease within ...
Jean‐François Lemaire   +1 more
doaj   +1 more source

Availability, price, and affordability of essential medicines to manage noncommunicable diseases : a national survey from Nepal [PDF]

open access: yes, 2019
The aim of this study was to evaluate the availability, price, and affordability of essential noncommunicable disease (NCD) medicines in Nepal. A cross-sectional survey was conducted in Nepal in 2015 using World Health Organization/Health Action ...
Ewen, Margaret   +4 more
core   +1 more source

Promoting transparency, accountability, and access through a multi-stakeholder initiative: lessons from the medicines transparency alliance

open access: yesJournal of Pharmaceutical Policy and Practice, 2017
Background Barriers to expanding access to medicines include weak pharmaceutical sector governance, lack of transparency and accountability, inadequate attention to social services on the political agenda, and financing challenges.
Taryn Vian   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy